Skip to main content

NeoGenomics BRCA1/2, Lynch Syndrome Testing Services

NeoGenomics has launched a new line of germline cancer predisposition testing services, including comprehensive testing for BRCA1/2 encompassing the analysis of all exons and adjacent intronic regions. Additionally, the firm launched germline testing for Lynch syndrome, which includes a comprehensive analysis for point mutations, indels, and large deletions in MLH1, MSH2, EPCAM, MSH6, and PMS2 genes.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.